Switch theme
Sign up to access all valuation multiples
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
2014
18.2K+
LTM Revenue $5.4B
LTM EBITDA $1.5B
$23.8B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Steris has a last 12-month revenue of $5.4B and a last 12-month EBITDA of $1.5B.
In the most recent fiscal year, Steris achieved revenue of $5.1B and an EBITDA of $1.4B.
Steris expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Steris valuation multiples based on analyst estimates| FY 2022 | FY 2023 | FY 2024 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $4.6B | $5.0B | $5.1B | $5.4B | XXX |
| Gross Profit | $2.0B | $2.2B | $2.2B | XXX | XXX |
| Gross Margin | 44% | 44% | 43% | XXX | XXX |
| EBITDA | $957M | $821M | $1.4B | $1.5B | XXX |
| EBITDA Margin | 21% | 17% | 27% | 28% | XXX |
| Net Profit | $244M | $107M | $378M | XXX | XXX |
| Net Margin | 5% | 2% | 7% | XXX | XXX |
| Net Debt | $2.7B | $2.9B | $3.0B | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of February 21, 2025, Steris's stock price is $221.
Steris has current market cap of $21.7B, and EV of $23.8B.
See Steris trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $23.8B | $21.7B | XXX | XXX | XXX | XXX | $9.01 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of February 21, 2025, Steris has market cap of $21.7B and EV of $23.8B.
Steris's trades at 4.4x LTM EV/Revenue multiple, and 15.6x LTM EBITDA.
Analysts estimate Steris's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Steris and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $23.8B | XXX | XXX | XXX |
| EV/Revenue | 4.4x | XXX | XXX | XXX |
| EV/EBITDA | 15.8x | XXX | XXX | XXX |
| P/E | 28.1x | XXX | XXX | XXX |
| P/E/Growth | 1.6x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpSteris's NTM/LTM revenue growth is 6%
Steris's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Steris's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Steris's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Steris and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 28% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 72% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 34% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 26% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Electromed | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Steris acquired XXX companies to date.
Last acquisition by Steris was XXXXXXXX, XXXXX XXXXX XXXXXX . Steris acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Steris founded? | Steris was founded in 2014. |
| Where is Steris headquartered? | Steris is headquartered in United States of America. |
| How many employees does Steris have? | As of today, Steris has 18.2K+ employees. |
| Who is the CEO of Steris? | Steris's CEO is Mr. Daniel A. Carestio. |
| Is Steris publicy listed? | Yes, Steris is a public company listed on NYS. |
| What is the stock symbol of Steris? | Steris trades under STE ticker. |
| When did Steris go public? | Steris went public in 1992. |
| Who are competitors of Steris? | Similar companies to Steris include e.g. Philips, Perspective Therapeutics, Electromed, InfuSystem. |
| What is the current market cap of Steris? | Steris's current market cap is $21.7B |
| What is the current revenue of Steris? | Steris's last 12-month revenue is $5.4B. |
| What is the current EBITDA of Steris? | Steris's last 12-month EBITDA is $1.5B. |
| What is the current EV/Revenue multiple of Steris? | Current revenue multiple of Steris is 4.4x. |
| What is the current EV/EBITDA multiple of Steris? | Current EBITDA multiple of Steris is 15.6x. |
| What is the current revenue growth of Steris? | Steris revenue growth between 2023 and 2024 was 4%. |
| Is Steris profitable? | Yes, Steris is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
